• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    2/14/24 4:24:23 PM ET
    $TALK
    Medical/Nursing Services
    Health Care
    Get the next $TALK alert in real time by email
    SC 13G/A 1 tm245429d39_sc13ga.htm SC 13G/A

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

     

    Under the Securities Exchange Act of 1934

    (Amendment No. 1)*

     

    Talkspace, Inc.

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    87427V103

    (CUSIP Number)

     

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    ¨Rule 13d-1(b)

     

    xRule 13d-1(c)

     

    ¨Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    Norwest Venture Partners XIII, LP
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    Delaware
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    0
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,702,972 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
    11. Percent of Class Represented by Amount in Row (9)
    8.8% (3)
    12. Type of Reporting Person (See Instructions)
    PN
             

    (1)This Schedule 13G is filed by Norwest Venture Partners XIII, LP (“NVP XIII”), Genesis VC Partners XIII, LLC (“Genesis XIII”), NVP Associates, LLC (“NVP Associates”), Jeffrey Crowe (“Crowe”), Promod Haque (“Haque”) and Jon E. Kossow (“Kossow” and, with NVP XIII, Genesis XIII, NVP Associates, Crowe and Haque, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the Securities and Exchange Commission (the “SEC”) on November 7, 2023.

     

    2

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    Genesis VC Partners XIII, LLC
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    Delaware
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    0
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,702,972 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
    11. Percent of Class Represented by Amount in Row (9)
    8.8% (3)
    12. Type of Reporting Person (See Instructions)
    OO
             

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    3

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    NVP Associates, LLC
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    Delaware
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    0
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,702,972 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
    11. Percent of Class Represented by Amount in Row (9)
    8.8% (3)
    12. Type of Reporting Person (See Instructions)
    OO
             

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    4

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    Jeffrey Crowe
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    United States of America
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    38,509 shares
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    38,509 shares
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,741,481 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
    11. Percent of Class Represented by Amount in Row (9)
    8.8%  (3)
    12. Type of Reporting Person (See Instructions)
    IN
             

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Includes 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    5

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    Promod Haque
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    United States of America
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    0
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,702,972 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ☐
    11. Percent of Class Represented by Amount in Row (9)
    8.8% (3)
    12. Type of Reporting Person (See Instructions)
    IN
             

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    6

     

     

    CUSIP No.   87427V103
    1. Names of Reporting Persons
    Jon E. Kossow
    2. Check the Appropriate Box if a Member of a Group (See Instructions)
      (a)
    (b)
    ¨
    x (1)
    3. SEC Use Only
    4. Citizenship or Place of Organization
    United States of America
    Number of
    Shares
    Beneficially
    Owned by
    Each
    Reporting
    Person With
    5. Sole Voting Power
    0
    6. Shared Voting Power
    14,702,972 shares (2)
    7. Sole Dispositive Power
    0
    8. Shared Dispositive Power
    14,702,972 shares (2)
    9. Aggregate Amount Beneficially Owned by Each Reporting Person
    14,702,972 shares (2)
    10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)    ¨
    11. Percent of Class Represented by Amount in Row (9)
    8.8% (3)
    12. Type of Reporting Person (See Instructions)
    IN
             

    (1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
    (2)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    7

     

     

    Item 1.
     
      (a)

    Name of Issuer

    Talkspace, Inc.

      (b)

    Address of Issuer’s Principal Executive Offices

    622 Third Avenue

    New York, NY 10017

    Item 2.
     
      (a)

    Name of Person Filing

    Norwest Venture Partners XIII, LP (“NVP XIII”)

    Genesis VC Partners XIII, LLC (“Genesis XIII”)

    NVP Associates, LLC (“NVP Associates”)

    Jeffrey Crowe (“Crowe”)

    Promod Haque (“Haque”)

    Jon E. Kossow (“Kossow”)

      (b)

    Address of Principal Business Office or, if none, Residence

    1300 El Camino Real, Suite 200

    Menlo Park, CA 94024

      (c)

    Citizenship

    Entities:          NVP XIII                -      Delaware

    Genesis XIII          -      Delaware

    NVP Associates   -      Delaware

    Individuals:  Crowe                     -      United States of America

    Haque                    -      United States of America

    Kossow                 -      United States of America

      (d)

    Title of Class of Securities

    Common Stock, $0.0001 par value per share

      (e)

    CUSIP Number

    87427V103

     
    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
       
      Not applicable
       
    Item 4. Ownership
       
    The following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1 is provided as of December 31, 2023:

     

    8

     

     

    Reporting
    Persons
      Shares Held
    Directly
       Sole
    Voting
    Power
       Shared
    Voting
    Power
       Sole
    Dispositive
    Power
       Shared
    Dispositive
    Power
       Beneficial
    Ownership
       Percentage
    of Class (3)
     
    NVP XIII (1)   14,702,972    0    14,702,972    0    14,702,972    14,702,972    8.8%
    Genesis XIII (1)   0    0    14,702,972    0    14,702,972    14,702,972    8.8%
    NVP Associates (1)   0    0    14,702,972    0    14,702,972    14,702,972    8.8%
    Crowe (2)   38,509    38,509    14,702,972    38,509    14,702,972    14,741,481    8.8%
    Haque (1)   0    0    14,702,972    0    14,702,972    14,702,972    8.8%
    Kossow (1)   0    0    14,702,972    0    14,702,972    14,702,972    8.8%

     

    (1)Consists of 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (2)Includes 14,702,972 shares of Common Stock held by Norwest Venture Partners XIII, LP. Genesis XIII is the general partner of NVP XIII, NVP Associates is the managing member of Genesis XIII and Crowe, Haque and Kossow are Co-Chief Executive Officers of NVP Associates. Each of Genesis XIII, NVP Associates, Crowe, Haque and Kossow, may be deemed to share voting and investment authority over these shares.
    (3)The percentage is based on 167,095,019 shares of Common Stock reported to be outstanding as of November 3, 2023 in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2023 as filed with the SEC on November 7, 2023.

     

    Item 5. Ownership of Five Percent or Less of a Class
       
      If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ¨
       
    Item 6. Ownership of More than Five Percent on Behalf of Another Person
       
      Not applicable
       
    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
       
      Not applicable
       
    Item 8. Identification and Classification of Members of the Group
       
      Not applicable
       
    Item 9. Notice of Dissolution of Group
       
      Not applicable
       
    Item 10. Certification
       
      By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

     

    9

     

     

    Signature

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

    Dated: February 14, 2024

     

    Norwest Venture Partners XIII, LP

     

    By Genesis VC Partners XIII, LLC  
    Its General Partner  
         
    By NVP Associates, LLC,  
    Its: Managing Member  

     

    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  

     

    Genesis VC Partners XIII, LLC

     

    By NVP Associates, LLC,  
    Its: Managing Member  

     

    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  

     

    NVP Associates, LLC

     

    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  

     

    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Promod Haque  

     

    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Jeffrey Crowe  

     

    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Jon E. Kossow  

     

      ATTENTION  
         
    Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

     

    10

     

     

    Exhibit(s):

     

    AJoint Filing Agreement

     

    11

     

     

    EXHIBIT A

     

    JOINT FILING AGREEMENT

     

    We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Talkspace, Inc. is filed on behalf of each of us.

     

    Dated: February 14, 2024

     

    Norwest Venture Partners XIII, LP  
       
    By Genesis VC Partners XIII, LLC  
    Its General Partner  
       
    By NVP Associates, LLC,  
    Its: Managing Member  
       
    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  
       
    Genesis VC Partners XIII, LLC  
       
    By NVP Associates, LLC,  
    Its: Managing Member  
       
    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  
       
    NVP Associates, LLC  
       
    By: /s/ Matthew De Dominicis  
      Name: Matthew De Dominicis  
      Title: Chief Financial Officer  
       
    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Promod Haque  
       
    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Jeffrey Crowe  
       
    /s/ Matthew De Dominicis  
    Matthew De Dominicis,  
    as Attorney-in-fact for Jon E. Kossow  

     

     

     

    Get the next $TALK alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TALK

    DatePrice TargetRatingAnalyst
    4/3/2025$5.00Buy
    Canaccord Genuity
    12/9/2024$4.50Overweight
    KeyBanc Capital Markets
    12/4/2024$5.00Outperform
    Mizuho
    11/20/2024$5.00Outperform
    Northland Capital
    7/1/2024Hold
    Needham
    1/3/2024$2.50Equal Weight
    Barclays
    12/2/2021$2.00Hold
    Jefferies
    11/16/2021$10.00 → $3.00Outperform → Neutral
    Robert W. Baird
    More analyst ratings

    $TALK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Talkspace Adopts Express Access—an AI-Powered Referral Infrastructure to Help PCPs and Employers Deliver Personalized Mental Health Care Faster Than Ever

    NEW YORK and BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Talkspace, a leading virtual behavioral health provider, and Express Access, the National Institutes of Health funded referral platform developed by Outcome Referrals, today announced a new partnership that will reshape how Americans access mental health care. Talkspace is the first national digital provider to fully adopt the Express Access TOP Match™ system at scale—integrating scientific provider matching and real-time patient progress tracking directly into its care model. Patients can now get Express Access through their employer or by scanning a free QR code offered by their primary care physician—instantly connecting them to ma

    8/12/25 8:03:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Participate in Upcoming Investor Conference

    NEW YORK, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that members of senior management will participate in the Canaccord Genuity 45th Annual Growth Conference, being held in Boston, including a fireside chat on Tuesday, August 12, 2025 at 1:30pm ET. A webcast link will be available on Talkspace's Investor Relations Website: https://investors.talkspace.com/. About Talkspace Talkspace (NASDAQ:TALK) is a leading virtual behavioral healthcare provider committed to helping people lead healthier, happier lives through access to high-quality mental healthcare. At Talkspace, we believe that mental healthcare is core to

    8/6/25 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces Second Quarter 2025 Results

    2Q 2025 Total revenue grew 18% year-over-year to $54.3 million driven by 35% year-over-year growth in Payor revenue 2Q 2025 Net loss of $0.5 million and adjusted EBITDA1 of $2.3 million 2Q 2025 Share repurchases of $1.4 million NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company")    (NASDAQ:TALK), today reported second quarter 2025 financial results.   Three Months Ended June 30,  Six Months EndedJune 30,   2025  2024  2025  2024 Unaudited Results  % Variancefrom PriorYear  Results  % Variancefrom PriorYear (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  385.1   29%  735.1   26%Number of unique

    8/5/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Harris Ian Jiro bought $86,037 worth of shares (30,844 units at $2.79), increasing direct ownership by 5% to 615,015 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/5/25 4:00:06 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R bought $214,500 worth of shares (75,000 units at $2.86), increasing direct ownership by 3% to 2,267,980 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    3/3/25 9:30:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Legal Officer, Secretary Reilly John Charles bought $10,242 worth of shares (3,600 units at $2.85), increasing direct ownership by 0.41% to 889,806 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    2/28/25 9:55:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Talkspace with a new price target

    Canaccord Genuity initiated coverage of Talkspace with a rating of Buy and set a new price target of $5.00

    4/3/25 8:18:33 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    KeyBanc Capital Markets initiated coverage on Talkspace with a new price target

    KeyBanc Capital Markets initiated coverage of Talkspace with a rating of Overweight and set a new price target of $4.50

    12/9/24 8:34:29 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Mizuho initiated coverage on Talkspace with a new price target

    Mizuho initiated coverage of Talkspace with a rating of Outperform and set a new price target of $5.00

    12/4/24 7:49:48 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    SEC Filings

    View All

    $TALK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 10-Q filed by Talkspace Inc.

    10-Q - Talkspace, Inc. (0001803901) (Filer)

    8/8/25 5:23:03 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Talkspace, Inc. (0001803901) (Filer)

    8/5/25 8:00:20 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SCHEDULE 13G filed by Talkspace Inc.

    SCHEDULE 13G - Talkspace, Inc. (0001803901) (Subject)

    7/29/25 2:40:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Technology Officer Margolin Gil sold $56,227 worth of shares (19,302 units at $2.91), decreasing direct ownership by 7% to 262,616 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/17/25 9:00:04 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Cohen Jon R covered exercise/tax liability with 83,978 shares, decreasing direct ownership by 3% to 2,489,082 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/12/25 9:00:05 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Chief Technology Officer Margolin Gil covered exercise/tax liability with 12,023 shares, decreasing direct ownership by 4% to 281,918 units (SEC Form 4)

    4 - Talkspace, Inc. (0001803901) (Issuer)

    6/12/25 9:00:08 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/14/24 4:24:23 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by Talkspace Inc. (Amendment)

    SC 13G/A - Talkspace, Inc. (0001803901) (Subject)

    2/9/24 7:24:33 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    SEC Form SC 13D/A filed by Talkspace Inc. (Amendment)

    SC 13D/A - Talkspace, Inc. (0001803901) (Subject)

    10/5/23 6:41:35 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Financials

    Live finance-specific insights

    View All

    Talkspace Announces Second Quarter 2025 Results

    2Q 2025 Total revenue grew 18% year-over-year to $54.3 million driven by 35% year-over-year growth in Payor revenue 2Q 2025 Net loss of $0.5 million and adjusted EBITDA1 of $2.3 million 2Q 2025 Share repurchases of $1.4 million NEW YORK, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company")    (NASDAQ:TALK), today reported second quarter 2025 financial results.   Three Months Ended June 30,  Six Months EndedJune 30,   2025  2024  2025  2024 Unaudited Results  % Variancefrom PriorYear  Results  % Variancefrom PriorYear (In thousands unless otherwise noted)            Number of completed Payor sessions during the period  385.1   29%  735.1   26%Number of unique

    8/5/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace to Report Second Quarter 2025 Results and Host Conference Call

    NEW YORK, July 21, 2025 (GLOBE NEWSWIRE) -- Talkspace (NASDAQ:TALK), a leading behavioral healthcare company, today announced that it will release its second quarter 2025 results on Tuesday, August 5, 2025, before market open and host a conference call to review the results at 8:30am ET. Conference Call DetailsThe conference call will be available via audio webcast at https://investors.talkspace.com/ and can also be accessed by dialing (888) 596-4144 for U.S. participants, or +1 (646) 968-2525 for international participants, and using conference ID 8668160. A replay will be available shortly after the call's completion and remain available for approximately 90 days. About TalkspaceTalksp

    7/21/25 4:05:00 PM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Announces First Quarter 2025 Results

    1Q 2025 Total revenue grew 15% year-over-year to $52.2 million driven by 33% year-over-year growth in Payor revenue 1Q 2025 Net income of $0.3 million and adjusted EBITDA1 of $2.0 million 1Q 2025 Share repurchases of $7.0 million NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Talkspace, Inc. ("Talkspace" or the "Company") (NASDAQ:TALK), today reported first quarter 2025 financial results.   Three Months Ended March 31, 2025     Unaudited Results % Variance fromPrior Year (In thousands unless otherwise noted)     Number of completed Payor sessions during the period  350.0  23% Number of Unique Active Payor members during the period  101.2  17%       Total revenue $52,182  15% G

    5/6/25 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    $TALK
    Leadership Updates

    Live Leadership Updates

    View All

    Talkspace Partners With Amazon Health Services to Help Millions Discover Mental Health Benefits

    New collaboration aims to improve awareness of, and expand access to, online therapy and psychiatry services to the 150+ million people who have Talkspace as a covered benefit Talkspace (NASDAQ:TALK), a leading online behavioral health care company, today announced a partnership with Amazon Health Services to increase awareness and discoverability of its mental health care services on Amazon.com. Talkspace is the first virtual behavioral health provider to join Amazon Health Services' program to help individuals discover and enroll in their health insurance benefits at no extra cost or for a small copay. With more than 5,000 therapists and providers across 50 states, Talkspace improves acc

    9/17/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace and the Professional Tennis Players Association Join Forces to Support Mental Health of Athletes Year Round

    Today, Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced its partnership with the Professional Tennis Players Association (PTPA), global advocates for professional tennis players. Talkspace will serve as the PTPA's exclusive mental health technology partner, granting players, their families, and their support teams free, 24/7 access to Talkspace's self-guided therapy app, Talkspace Go, as well as discounted access to its virtual therapy offering. "Talkspace is honored to join forces with the PTPA as its exclusive mental health provider, dedicated to delivering high-quality, evidence-based support where and when players need it. This collaboration undersco

    8/28/24 9:06:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care

    Talkspace Appoints John Mooney as Chief Product Officer

    NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Today Talkspace (NASDAQ:TALK), a leading online behavioral health care company, announced the appointment of John Mooney as its new Chief Product Officer, to lead the company's growth initiatives, product strategy and design. Through his work for startup digital health, behavioral health, and diagnostics companies, Mr. Mooney has deep domain expertise in healthcare data, building out platform capabilities and optimizing workflows. "John has spent his career driving innovation for a range of high-growth, high-performing healthcare companies," said Dr. Jon Cohen, Chief Executive Officer, Talkspace. "We look forward to his expertise leveraging dat

    6/5/24 8:00:00 AM ET
    $TALK
    Medical/Nursing Services
    Health Care